SEARCH

SEARCH BY CITATION

References

  • Balsinde J. and Dennis E. A. (1996) Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J. Biol. Chem. 271, 67586765.
  • Berg K. A., Clarke W. P., Sailstad C., Saltzman A. and Maayani S. (1994) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol. 46, 477484.
  • Berg K. A., Maayani S., Goldfarb J., Scaramellini C., Leff P. and Clarke W. P. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54, 94104.
  • Berridge M. J., Dawson R. M., Downes C. P., Heslop J. P. and Irvine R. F. (1983) Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212, 473482.
  • Burch R. M. and Axelrod J. (1987) Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2. Proc. Natl Acad. Sci. USA 84, 63746378.
  • Burch R. M., Luini A. and Axelrod J. (1986) Phospholipase A2 and phospholipase C are activated by distinct GTP-binding proteins in response to alpha 1-adrenergic stimulation in FRTL5 thyroid cells. Proc. Natl Acad. Sci. USA 83, 72017205.
  • Capper E. A. and Marshall L. A. (2001) Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis. Prog. Lipid Res. 40, 167197.
  • Chen Z., Wells C. D., Sternweis P. C. and Sprang S. R. (2001) Structure of the rgRGS Domain of p115RhoGEF. Nat. Struct. Biol. 8, 805809.
  • Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N. and Knopf J. L. (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65, 10431051.
  • Clark J. D., Schievella A. R., Nalefski E. A. and Lin L. L. (1995) Cytosolic phospholipase A2. J. Lipid Med. Cell Signal 12, 83117.
  • Communal C., Colucci W. S. and Singh K. (2000) P38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J. Biol. Chem. 275, 1939519400.
  • Dermott J. M., Reddy M. R., Onesime D., Reddy E. P. and Dhanasekaran N. (1999) Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene 18, 71857189.
  • Dhanasekaran N. and Dermott J. M. (1996) Signaling by the G12 class of G proteins. Cell Signal. 8, 235245.
  • Felder C. C., Kanterman R. Y., Ma A. L. and Axelrod J. (1990) Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl Acad. Sci. USA 87, 21872191.
  • Florian J. A. and Watts S. W. (1998) Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J. Pharmacol. Exp. Ther. 284, 346355.
  • Fonteh A. N., Bass D. A., Marshall L. A., Seeds M., Samet J. M. and Chilton F. H. (1994) Evidence that secretory phospholipase A2 Plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J. Immunol. 152, 54385446.
  • Geijsen N., Dijkers P. F., Lammers J. J., Koenderman L. and Coffer P. J. (2000) Cytokine-mediated CPLA(2) phosphorylation is regulated by multiple MAPK family members. FEBS Lett. 471, 8388.
  • Ghahremani M. H., Cheng P., Lembo P. M. and Albert P. R. (1999) Distinct roles for Galphai2, Galphai3, and Gbeta gamma in modulation of forskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J. Biol. Chem. 274, 92389245.
  • Gijon M. A., Spencer D. M., Kaiser A. L. and Leslie C. C. (1999) Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2. J. Cell Biol. 145, 12191232.
  • Gupta S. K., Diez E., Heasley L. E., Osawa S. and Johnson G. L. (1990) A G protein mutant that inhibits thrombin and purinergic receptor activation of phospholipase A2. Science 249, 662666.
  • Hall R. A., Premont R. T. and Lefkowitz R. J. (1999) Heptahelical receptor signaling: beyond the G protein paradigm. J. Cell Biol. 145, 927932.
  • Hart M. J., Jiang X., Kozasa T., Roscoe W., Singer W. D., Gilman A. G., Sternweis P. C. and Bollag G. (1998) Direct stimulation of the guanine nucleotide exchange activity of P115 RhoGEF by Galpha13. Science 280, 21122114.
  • Hawes B. E., Van Biesen T., Koch W. J., Luttrell L. M. and Lefkowitz R. J. (1995) Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270, 1714817153.
  • Hernandez M., Burillo S. L., Crespo M. S. and Nieto M. L. (1998) Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273, 606612.
  • Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. (1994) International union of pharmacology classification of receptors for 5- hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157203.
  • Jelsema C. L. and Axelrod J. (1987) Stimulation of phospholipase A2 activity in bovine rod outer segments by the beta gamma subunits of transducin and its inhibition by the alpha subunit. Proc. Natl Acad. Sci. USA 84, 36233627.
  • Katada T. and Ui M. (1982) Direct modification of the membrane adenylate cyclase system by islet- activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl Acad. Sci. USA 79, 31293133.
  • Katoh H., Aoki J., Yamaguchi Y., Kitano Y., Ichikawa A. and Negishi M. (1998) Constitutively active Galpha12, Galpha13, and Galphaq induce rho-dependent neurite retraction through different signaling pathways. J. Biol. Chem. 273, 2870028707.
  • Kelleher M. D., Abe M. K., Chao T. S., Jain M., Green J. M., Solway J., Rosner M. R. and Hershenson M. B. (1995) Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis. Am. J. Physiol. 268, L894L901.
  • Kim B. C. and Kim J. H. (1997) Nuclear signalling by Rac GTPase: essential role of phospholipase A2. Biochem. J. 326, 333337.
  • Kramer R. M. and Sharp J. D. (1997) Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (CPLA2). FEBS Lett. 410, 4953.
  • Kramer R. M., Roberts E. F., Strifler B. A. and Johnstone E. M. (1995) Thrombin induces activation of P38 MAP kinase in human platelets. J. Biol. Chem. 270, 2739527398.
  • Kurrasch-Orbaugh D. M., Watts V. J., Barker E. L. and Nichols D. E. (2003) Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J. Pharmacol. Exp. Ther. 304, 229237.
  • Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A. and Davis R. J. (1993) CPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269278.
  • Luttrell L. M., Della Rocca G. J., Van Biesen T., Luttrell D. K. and Lefkowitz R. J. (1997) Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272, 46374644.
  • Mansour S. J., Candia J. M., Gloor K. K. and Ahn N. G. (1996) Constitutively active mitogen-activated protein kinase kinase 1 (MAPKK1) and MAPKK2 mediate similar transcriptional and morphological responses. Cell Growth Differ. 7, 243250.
  • Mao J., Yuan H., Xie W. and Wu D. (1998) Guanine nucleotide exchange factor GEF115 specifically mediates activation of rho and serum response factor by the G protein alpha subunit Galpha13. Proc. Natl Acad. Sci. USA 95, 1297312976.
  • Murakami M., Nakatani Y. and Kudo I. (1996) Type II secretory phospholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem. 271, 3004130051.
  • Murakami M., Nakatani Y., Atsumi G., Inoue K. and Kudo I. (1997) Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17, 225283.
  • Murakami M., Shimbara S., Kambe T., Kuwata H., Winstead M. V., Tischfield J. A. and Kudo I. (1998) The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release: type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273, 1441114423.
  • Nemenoff R. A., Winitz S., Van Qian N. X. P. V., Johnson G. L. and Heasley L. E. (1993) Phosphorylation and activation of a high molecular weight form of phospholipase A2 by P42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268, 196064.
  • Neve R. L., Howe J. R., Hong S. and Kalb R. G. (1997) Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant Herpes simplex virus. Neuroscience 79, 435447.
  • Sa G. and Das T. (1999) Basic fibroblast growth factor stimulates cytosolic phospholipase A2, phospholipase C-gamma1 and phospholipase D through distinguishable signaling mechanisms. Mol. Cell Biochem. 198, 1930.
  • Sah V. P., Seasholtz T. M., Sagi S. A. and Brown J. H. (2000) The role of rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharmacol. Toxicol. 40, 459489.
  • Sekine A., Fujiwara M. and Narumiya S. (1989) Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. J. Biol. Chem. 264, 86028605.
  • Selbie L. A., King N. V., Dickenson J. M. and Hill S. J. (1997) Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U) receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. Biochem. J. 328, 153158.
  • Sharp J. D., White D. L., Chiou X. G., Goodson T., Gamboa G. C., McClure D., Burgett S., Hoskins J., Skatrud P. L. and Sportsman J. R. (1991) Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J. Biol. Chem. 266, 1485014853.
  • Tolkacheva T., Feuer B., Lorenzi M. V., Saez R. and Chan A. M. (1997) Cooperative transformation of NIH3T3 cells by G alpha12 and Rac1. Oncogene 15, 727735.
  • Tournois C., Mutel V., Manivet P., Launay J. M. and Kellermann O. (1998) Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line: involvement of arachidonic acid metabolism. J. Biol. Chem. 273, 1749817503.
  • Watts S. W. (1996) Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J. Pharmacol. Exp. Ther. 279, 15411550.
  • Wilson K. P., McCaffrey P. G., Hsiao K., Pazhanisamy S., Galullo V., Bemis G. W., Fitzgibbon M. J., Caron P. R., Murcko M. A. and Su M. S. (1997) The structural basis for the specificity of pyridinylimidazole inhibitors of P38 MAP kinase. Chem. Biol. 4, 423431.
  • Xu N., Bradley L., Ambdukar I. and Gutkind J. S. (1993) A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proc. Natl Acad. Sci. USA 90, 67416745.
  • Yamauchi J., Tsujimoto G., Kaziro Y. and Itoh H. (2001) Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade. J. Biol. Chem. 276, 2336223372.
  • Yoo M. H., Woo C. H., You H. J., Cho S. H., Kim B. C., Choi J. E., Chun J. S., Jhun B. H., Kim T. S. and Kim J. H. (2001) Role of the cytosolic phospholipase A2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform. J. Biol. Chem. 276, 2464524653.
  • Zohn I. M., Campbell S. L., Khosravi-Far R., Rossman K. L. and Der C. J. (1998) Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17, 14151438.